Representatives of the Council of the European Union, the European Parliament and the European Commission hope to conclude their negotiations on Monday 25 September on the proposal concerning fees and charges payable to the European Medicines Agency (EMA).
This is the second, and possibly the last, trilogue on this issue.
The main points to be discussed are the level of fees and remuneration due to the EMA to ensure the sustainability of the network made up of the EMA and the national...